Experienced in Tethered Cord Syndrome

Alf K. Giese

Mainz, RP, DE 
Experienced in Tethered Cord Syndrome
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Alf Giese practices in Mainz, Germany. Mr. Giese is rated as an Experienced expert by MediFind in the treatment of Tethered Cord Syndrome. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Spinal Fusion, and Osteotomy.

His clinical research consists of co-authoring 79 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Tethered Cord Syndrome.

Gender
Male

Locations

Mainz, RP 55131, Germany
Other Locations
Hamburg, HH 20149, Germany
Hannover, NI, Germany
Rostock, MV, Germany
Greifswald, MV, Germany
St Josef Hospital, Gudrunstraße 56, Bochum, NW 44791, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Non-Randomized, Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM System to Transcranial Doppler or DSA as an Aid to Diagnosing Vasospasm
A Non-Randomized, Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM System to Transcranial Doppler or DSA as an Aid to Diagnosing Vasospasm
Enrollment Status: Terminated
Publish Date: July 01, 2022
Intervention Type: Device

79 Total Publications

Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer.
Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer.
Journal: Cells
Published: March 26, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Giese's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile